Narinder Singh, MD
Family Medicine · San Dimas, CANPI 1841867439
Payments from drug & device makers
Across 81 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$376
- Indivior Inc.$350
- Alkermes, Inc.$149
- Lundbeck LLC$138
- Pfizer$123
- Novo Nordisk$99
- plus $753 from 19 others
What the payments were for
- Food & beverage$1,988100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $376 |
| Indivior Inc. | 11 | $350 |
| Alkermes, Inc. | 6 | $149 |
| Lundbeck LLC | 7 | $138 |
| Pfizer | 4 | $123 |
| Novo Nordisk | 4 | $99 |
| Almatica Pharma LLC | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Viiv Healthcare Company | 2 | $64 |
| AstraZeneca | 2 | $50 |
| Braeburn Inc. | 1 | $39 |
| Gilead | 2 | $39 |
| Exact Sciences | 2 | $36 |
| IBSA Pharma Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Merck | 1 | $35 |
| Ardelyx, Inc. | 1 | $32 |
| Eisai Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $28 |
| GSK | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Organon | 1 | $14 |
How this compares
$1,988 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in San Dimas
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.